Categories: HospitalsNews

Hospitals Preparing for Surge of Summer Births With Support From US Med-Equip

HOUSTON, TX / ACCESSWIRE / May 9, 2024 / As hospitals prepare for the summer months, a period traditionally marked by an increase in births, including newborns delivered pre-term, US Med-Equip is helping clinicians bolster supplies of medical equipment used for labor and delivery and neonatal care.

US Med-Equip
Credit: Gentherm Medical. Infant using Gentherm Neonate Kool-Kit.

Hospitals typically get an annual surge of births from June through August. Bolstering equipment in labor and delivery (L&D) and Neonatal Intensive Care Unit (NICU) departments during these summer months is crucial for the survival and long-term health of a newborn.

Amid prolonged strain on clinical staff and budgets, hospitals nationwide are turning to trusted partner US Med-Equip for the rental, purchase, and maintenance of NICU and L&D equipment, including birthing beds, incubators, ventilators, and temperature management and monitoring systems.

“Our goal is ensuring clinicians have affordable access to the best equipment and services, so they can focus fully on providing care to mothers and newborns requiring their attention,” Greg Salario, CEO of US Med-Equip, said.

US Med-Equip’s caring professionals across the country deliver equipment hospitals need on-demand based on the number of patients expected or admitted at the time.

About US Med-Equip
US Med-Equip partners with top hospitals across the nation to provide the highest-quality movable medical equipment, beds and therapeutic surfaces for patients in their care.

Contact Information

Buse Kayar
buse.kayar@issuerdirect.com

Related Images

US Med-Equip
Credit: Gentherm Medical. Infant using Gentherm Neonate Kool-Kit.
US Med-Equip
Birthing Rise Chart 2022

SOURCE: US Med-Equip

View the original press release on newswire.com.

Staff

Recent Posts

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…

4 hours ago

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…

4 hours ago